Suppr超能文献

2003年尿液分离株对抗菌药物的敏感性调查。

Survey of the susceptibility of urinary isolates to antibacterial agents in 2003.

作者信息

Ishikawa Kiyohito, Hayakawa Satoshi, Miyakawa Shinzaburo, Kusaka Mamoru, Shiroki Ryoichi, Hoshinaga Kiyotaka

机构信息

Department of Urology, School of Medicine, Fujita Health University, 1-98 Dengakugakubo Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.

出版信息

J Infect Chemother. 2005 Feb;11(1):44-7. doi: 10.1007/s10156-004-0356-9.

Abstract

In 2003, 826 uropathogenic strains were obtained from the urine of our patients. We assessed their activities to antibacterial agents based on the minimal inhibitory concentration (MIC) breakpoints recommended by the National Committee for Clinical Standards (NCCLS). Methicillin-resistant strains accounted for about 70% of Staphylococcus aureus and Staphylococcus epidermidis. The most common gram-positive species was Enterococcus faecalis (15.6%). Enterococcus faecium was the most resistant of the enterococcal species, and the rate of susceptibility to beta-lactams (BLs), fluoroquinolones (FQs), and tetracyclines (TCs) was 0%, 6%, and less than 18%, respectively. Escherichia coli accounted for over 50% of the gram-negative bacilli. The proportion of FQ-resistant or intermediate strains was over 20%, and four of these strains (1.1%) were suspected of producing extended-spectrum beta-lactamase (ESBL). All the ESBL-producing strains (ESBLs) possess resistance to FQs. Over 95% of Klebsiella pneumoniae was susceptible to all agents. The distribution of antimicrobial activity against Pseudomonas aeruginosa indicated a decrease in the number of multidrug-resistant strains and an increase in strains susceptible to all agents. Some differences existed in the resistance to antibacterial agents among Proteus species. No ESBL-producing or multidrug-resistant strain was isolated from Serratia marcescens. This survey suggests that serious clinical problems will result from the increasing number of enterococcal species with multidrug resistance in gram-positive cocci, and isolates of ESBL-producing or FQs-resistant strains in gram-negative bacilli.

摘要

2003年,我们从患者尿液中分离出826株尿路致病性菌株。我们根据美国国家临床实验室标准委员会(NCCLS)推荐的最低抑菌浓度(MIC)断点评估了它们对抗菌药物的敏感性。耐甲氧西林菌株约占金黄色葡萄球菌和表皮葡萄球菌的70%。最常见的革兰氏阳性菌是粪肠球菌(15.6%)。屎肠球菌是肠球菌属中耐药性最强的,对β-内酰胺类(BLs)、氟喹诺酮类(FQs)和四环素类(TCs)的敏感率分别为0%、6%和低于18%。大肠埃希菌占革兰氏阴性杆菌的50%以上。耐FQ或中介菌株的比例超过20%,其中4株(1.1%)怀疑产超广谱β-内酰胺酶(ESBL)。所有产ESBL菌株均对FQ耐药。超过95%的肺炎克雷伯菌对所有药物敏感。对铜绿假单胞菌的抗菌活性分布表明,多重耐药菌株数量减少,对所有药物敏感的菌株数量增加。变形杆菌属之间对抗菌药物的耐药性存在一些差异。未从粘质沙雷菌中分离出产ESBL或多重耐药菌株。这项调查表明,革兰氏阳性球菌中多重耐药肠球菌种类的增加,以及革兰氏阴性杆菌中产ESBL或耐FQ菌株的分离株,将导致严重的临床问题。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验